Analysts Set Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Target Price at $9.83
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) has received an average recommendation of “Buy” from the eight brokerages that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, five have given a buy rating and two have assigned a strong buy rating to the company. […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Free Report) has received an average recommendation of “Buy” from the eight brokerages that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating, five have given a buy rating and two have assigned a strong buy rating to the company. […]
